303779-66-0

Basic information

• Product Name: 3-Bromonaphthalene-1-carboxaldehyde
• Synonyms: 3-Bromonaphthalene-1-carboxaldehyde
• CAS NO: 303779-66-0
• Molecular Formula: C11H7BrO
• Molecular Weight: 235.07668
• Mol File: 303779-66-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Bromonaphthalene-1-carboxaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromonaphthalene-1-carboxaldehyde(303779-66-0)
• EPA Substance Registry System: 3-Bromonaphthalene-1-carboxaldehyde(303779-66-0)

Safety Data

• Hazardous Substances Data: 303779-66-0(Hazardous Substances Data)

Upstream product

• 80063-50-9 3-bromo-1-bromomethylnaphthalene 
• 112929-89-2 3-bromo-1-methyl-naphthalene 
• 796112-05-5 3-bromo-N-methoxy-N-methyl-1-naphthamide 
• 16726-66-2 3-bromo-1-naphthoic acid 

Relevant articles and documents

Palladium-Catalyzed Regiospecific peri- And ortho-C-H Oxygenations of Polyaromatic Rings Mediated by Tunable Directing Groups

An efficient divergent approach of Pd-catalyzed C-H oxygenation of polyaromatic rings is described. Reversible directing groups enable regiospecific peri- and ortho-oxygenation to readily access a wide array of polyaromatic phenols without pre- and postmanipulation of directing groups. The systematic mechanistic investigation, including deuterium-labeling experiments, palladacycle trapping, and DFT calculations, reveals that the tunable ligand-assisted C-H bond cleavage played a crucial role during the reaction process.

Concise Synthesis of Natural Phenylphenalenone Phytoalexins and a Regioisomer

Concise total syntheses of the natural phytoalexins 2-hydroxy-8-(4-hydroxyphenyl)phenalen-1-one (1), 2-hydroxy-8-(3,4-dihydroxyphenyl)phenalen-1-one (2), and hydroxyanigorufone (4), together with regioisomer 3 are accomplished in 11 or 12 steps. The synthetic strategy features a Friedel-Crafts acylation to construct the 1H-phenalen-1-one tricyclic core followed by a Suzuki cross-coupling to obtain the target compounds.

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

The present invention provides a compound having a lysine-specific demethylase-1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for schizophrenia, developmental disorders, particularly diseases having intellectual disability (e.g., autistic spectrum disorders, Rett syndrome, Down's syndrome, Kabuki syndrome, fragile X syndrome, Kleefstra syndrome, neurofibromatosis type 1, Noonan syndrome, tuberous sclerosis), neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, spinocerebellar degeneration (e.g., dentatorubural pallidoluysian atrophy) and Huntington's disease), epilepsy (e.g., Dravet syndrome) or drug dependence, and the like. A compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.

Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations

The present invention relates to a novel pyrrole derivative which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof; to a process for preparation of said compound; and to a pharmaceutical composition such as anti-cancer composition, etc. comprising said compound as an active ingredient together with pharmaceutically acceptable carrier.